Octaarginine Improves the Efficacy of Nitazoxanide against <i>Cryptosporidium parvum</i>
Cryptosporidiosis is an intestinal disease that affects a variety of hosts including animals and humans. Since no vaccines exist against the disease till date, drug treatment is the mainstay of disease control. Nitazoxanide (NTZ) is the only FDA-approved drug for the treatment of human cryptosporidi...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2022-06-01
|
| Series: | Pathogens |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2076-0817/11/6/653 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|